Dadras Omid, SeyedAlinaghi SeyedAhmad, Karimi Amirali, Shojaei Alireza, Amiri Ava, Mahdiabadi Sara, Fakhfouri Amirata, Razi Armin, Mojdeganlou Hengameh, Mojdeganlou Paniz, Barzegary Alireza, Pashaei Zahra, Afsahi Amir Masoud, Shobeiri Parnian, Mehraeen Esmaeil
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Arch Acad Emerg Med. 2022 Jul 4;10(1):e53. doi: 10.22037/aaem.v10i1.1582. eCollection 2022.
Controversies existed regarding the duration of COVID-19 vaccines' protection and whether receiving the usual vaccine doses would be sufficient for long-term immunity. Therefore, we aimed to systematically review the studies regarding the COVID-19 vaccines' protection three months after getting fully vaccinated and assess the need for vaccine booster doses.
The relevant literature was searched using a combination of keywords on the online databases of PubMed, Scopus, Web of Science, and Cochrane on September 17th, 2021. The records were downloaded and the duplicates were removed. Then, the records were evaluated in a two-step process, consisting of title/abstract and full-text screening processes, and the eligible records were selected for the qualitative synthesis. We only included original studies that evaluated the efficacy and immunity of COVID-19 vaccines three months after full vaccination. This review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement to ensure the reliability of results.
Out of the 797 retrieved records, 12 studies were included, 10 on mRNA-based vaccines and two on inactivated vaccines. The majority of included studies observed acceptable antibody titers in most of the participants even after 6 months; however,it appeared that the titers could also decrease in a considerable portion of people. Due to the reduction in antibody titers and vaccine protection, several studies suggested administering the booster dose, especially for older patients and those with underlying conditions, such as patients with immunodeficiencies.
Studies indicated that vaccine immunity decreases over time, making people more susceptible to contracting the disease. Besides, new variants are emerging, and the omicron variant is continuing to spread and escape from the immune system, indicating the importance of a booster dose.
关于新冠疫苗保护期的时长以及常规剂量疫苗是否足以提供长期免疫力存在争议。因此,我们旨在系统回顾关于完全接种疫苗三个月后新冠疫苗保护作用的研究,并评估加强剂量疫苗的必要性。
2021年9月17日,在PubMed、Scopus、Web of Science和Cochrane在线数据库上使用关键词组合搜索相关文献。下载记录并去除重复项。然后,通过标题/摘要和全文筛选两步流程对记录进行评估,选择符合条件的记录进行定性综合分析。我们仅纳入评估完全接种疫苗三个月后新冠疫苗效力和免疫情况的原始研究。本综述遵循系统评价和Meta分析的首选报告项目(PRISMA)声明,以确保结果的可靠性。
在检索到的797条记录中,纳入了12项研究,其中10项关于基于mRNA的疫苗,2项关于灭活疫苗。大多数纳入研究观察到,即使在6个月后,大多数参与者的抗体滴度仍处于可接受水平;然而,相当一部分人的抗体滴度似乎也会下降。由于抗体滴度和疫苗保护作用降低,一些研究建议接种加强剂量疫苗,特别是对于老年患者和有基础疾病的患者,如免疫缺陷患者。
研究表明,疫苗免疫力会随着时间下降;这使得人们更容易感染疾病。此外,新的病毒变种不断出现,奥密克戎变种仍在持续传播并能逃避免疫系统,这表明接种加强剂量疫苗的重要性。